Amphastar Antitrust Claims Nixed In Lovenox Suit
In a setback for Amphastar Pharmaceuticals Inc., a federal judge has dismissed its cross-claims that two Sanofi-Aventis subsidiaries engaged in anti-competitive conduct and unfair competition by obtaining and enforcing through fraud...To view the full article, register now.
Already a subscriber? Click here to view full article